The MAGOH/hnRNPH1 axis promotes alternative splicing-derived soluble PD-L1 generation and attenuates PD-L1 blockade efficacy in gastric cancer
Year: 2026
Type: article
Abstract: Despite the clinical success of PD-1 blockade, the therapeutic efficacy of PD-L1 blockade in gastric cancer (GC) remains limited. Soluble PD-L1 (sPD-L1) has been proposed to function as a decoy that sequesters anti-PD-L1 antibodies, potentially contributing to therapeutic resistance. Our previous study identified an exon 5/6-skipping PD-L1 splice variant, designated PD-L1-v1, as an important source of sPD-L1 in GC. We also found that MAGOH is highly expressed in GC and participates in alternative splicing regulation. Here, we demonstrate that PD-L1-v1 acts as a soluble decoy that limits PD-L1 blocker binding to membrane-bound PD-L1 on tumor cells, thereby impairing the antitumor efficacy of PD-L1 blockade. Mechanistically, MAGOH upregulates hnRNPH1 expression, primarily by enhancing its mRNA stability, and promotes hnRNPH1-dependent exon5/6 skipping of PD-L1 pre-mRNA, thereby facilitating PD-L1-v1 and sPD-L1 generation. These findings reveal a previously unrecognized mechanism of resistance to PD-L1 blockade and highlight the MAGOH/hnRNPH1 axis as a potential strategy for improving immunotherapy efficacy in GC.
Source: Cell Communication and Signaling
Institution: First Affiliated Hospital Zhejiang University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,390
Award: G8564080142
OpenAlex ID: W7234297777
